Information Provided By:
Fly News Breaks for November 11, 2019
KALA
Nov 11, 2019 | 07:13 EDT
H.C. Wainwright analyst Yi Chen lowered his price target for Kala Pharmaceuticals to $10 from $12 and reiterates a Buy rating on the shares following the company's Q3 results. The analyst reduced his projected sales of Inveltys going forward.
News For KALA From the Last 2 Days
There are no results for your query KALA